Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04330976 · ClinicalTrials.gov registry record · NA

Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC

A NA study of Gestational Weight Gain, sponsored by University of Hawaii.

Completed
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT04330976: Completed NA study of Gestational Weight Gain, sponsored by University of Hawaii.

NCT04330976 is a NA study of Gestational Weight Gain that has completed, run by University of Hawaii. The registered enrollment target is 83 participants, below the 481-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04330976, a NA study of Gestational Weight Gain, has completed, sponsored by University of Hawaii.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The objective of this trial was to investigate the effect of educational short message service (SMS), or text messages, on gestational weight gain (GWG) in a low-income population.

Primary Outcome

Total weight gained during pregnancy

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Nutrition and physical activity intervention

Study Locations (1)

Hawaii

  • University of Hawaii - Honolulu

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2017-10-30
Est. Completion 2019-06-02
Phase NA
University of Hawaii

77 total trials

What the finished NCT04330976 record still lists

NCT04330976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 481-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Gestational Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT04330976 reports a single indexed study location in Hawaii.

Frequently Asked Questions

What is clinical trial NCT04330976 about?

NCT04330976 is a clinical study titled "Preventing Excessive Gestational Weight Gain Via Short Mobile Messages in WIC". The objective of this trial was to investigate the effect of educational short message service (SMS), or text messages, on gestational weight gain (GWG) in a low-income population.

What is the current status of trial NCT04330976?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2017-10-30. Estimated completion is 2019-06-02.

What conditions does trial NCT04330976 study?

This clinical trial studies the following conditions: Gestational Weight Gain.

What interventions are being tested in trial NCT04330976?

The interventions under investigation include: Control (BEHAVIORAL), Nutrition and physical activity intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04330976?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04330976 being conducted?

This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Weight Gain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04330976, the US trial registry maintained by the National Library of Medicine. NCT04330976 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.